A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib and rituximab for previously treated patients with chronic lymphocytic leukaemia (CLL) (NCRN375) Meeting Abstract
| Authors: | Hillmen, P.; Furman, R.; Sharmann, J.; Coutre, S.; Cheson, B.; Pagel, J.; Barrientos, J. M.; Zelenetz, A.; Kipps, T.; Pettitt, A.; Wallis, J.; Duncombe, A.; Dearden, C.; Follows, G.; Macdonald, D.; Moosa, A.; Panoskaltsis, N.; De Lord, C.; McCarthy, H.; O'Brien, S. |
| Abstract Title: | A phase 3, randomized, double-blind, placebo-controlled study evaluating the efficacy and safety of idelalisib and rituximab for previously treated patients with chronic lymphocytic leukaemia (CLL) (NCRN375) |
| Meeting Title: | 54th Annual Scientific Meeting of the British Society for Haematology |
| Journal Title: | British Journal of Haematology |
| Volume: | 165 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2014 Apr 28-30 |
| Meeting Location: | Birmingham, UK |
| ISSN: | 0007-1048 |
| Publisher: | John Wiley & Sons |
| Date Published: | 2014-05-01 |
| Start Page: | 3 |
| Language: | English |
| ACCESSION: | WOS:000334923300005 |
| PROVIDER: | wos |
| DOI: | 10.1111/bjh.12802 |
| Notes: | Meeting Abstract: 4 -- 54th Annual Scientific Meeting of the British-Society-for-Haematology -- APR 28-30, 2014 -- Birmingham, ENGLAND -- 1 -- SI -- Source: Wos |
